Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
In a prospective, randomized, single-blind, single-center, controlled study, we compared the effectiveness of single doses of cimetidine 800 mg, ranitidine 300 mg, and famotidine-40 mg given either as evening or morning doses for duodenal ulcer healing. One hundred eighty-six male patients with endoscopically confirmed duodenal ulcer were treated for 6 wk, and ulcer healing was endoscopically evaluated. The duodenal ulcer healing rate for each of the three H2-receptor antagonists was always less after morning administration than was achieved with the respective evening regimen: 59% versus 86% for cimetidine, 83% versus 94% for ranitidine, and 93% versus 97% for famotidine, but the difference was statistically significant for cimetidine only. This study confirms the importance of nocturnal therapy for duodenal ulcer healing. The importance is obscured when H2-receptor antagonists with higher potency and long duration of action are used.
Khasawneh
S M
SM
Department of Medicine, King Hussein Medical Center, Amman, Jordan.
Affarah
H B
HB
D000328:Adult; D002927:Cimetidine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004381:Duodenal Ulcer / Q000188:drug therapy*; D015738:Famotidine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011899:Ranitidine / Q000008:administration & dosage / Q000627:therapeutic use*; D016037:Single-Blind Method
D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine